TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs61440199
log Bayes Factor = 0.0319896
Chromosome 3   position 20,111,546  (GRCh37) Explore rs61440199 on Ensembl!
Variant rs61440199 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
T39.1 4-Aminophenol derivatives
0.000 0.951 0.049
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.957 0.043
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.961 0.039
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.962 0.038
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.964 0.036
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.966 0.034
T39.0 Salicylates
0.000 0.966 0.034
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.968 0.032
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.969 0.031
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.969 0.031
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.969 0.031
T39.4 Antirheumatics, not elsewhere classified
0.000 0.969 0.031
T39.2 Pyrazolone derivatives
0.000 0.969 0.031
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.969 0.031
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.969 0.031
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.969 0.030
T43.2 Other and unspecified antidepressants
0.000 0.970 0.030
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.970 0.030
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.971 0.028
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.971 0.028
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.971 0.028
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.971 0.028
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.971 0.028
T36 Poisoning by systemic antibiotics
0.000 0.971 0.028
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.973 0.027
T43.9 Psychotropic drug, unspecified
0.000 0.973 0.027
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.973 0.027
T43.6 Psychostimulants with abuse potential
0.000 0.973 0.027
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.973 0.027
T40.2 Other opioids
0.000 0.973 0.027
T42.4 Benzodiazepines
0.000 0.974 0.026
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.974 0.026
T45.0 Antiallergic and antiemetic drugs
0.000 0.974 0.026
T50.8 Diagnostic agents
0.000 0.975 0.025
T50.7 Analeptics and opioid receptor antagonists
0.000 0.975 0.025
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.975 0.025
T50.5 Appetite depressants
0.000 0.975 0.025
T50.4 Drugs affecting uric acid metabolism
0.000 0.975 0.025
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.975 0.025
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.975 0.025
T50.1 Loop [high-ceiling] diuretics
0.000 0.975 0.025
T50.0 Mineralocorticoids and their antagonists
0.000 0.975 0.025
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.975 0.025
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.976 0.024
C91.1 Chronic lymphocytic leukaemia
0.000 0.976 0.024
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.976 0.024
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.977 0.023
T45.8 Other primarily systemic and haematological agents
0.000 0.977 0.023
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.977 0.023
T45.6 Fibrinolysis-affecting drugs
0.000 0.977 0.023
T45.5 Anticoagulants
0.000 0.977 0.023
T45.4 Iron and its compounds
0.000 0.977 0.023
T45.3 Enzymes, not elsewhere classified
0.000 0.977 0.023
T45.2 Vitamins, not elsewhere classified
0.000 0.977 0.023
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.977 0.023
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.978 0.022
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.978 0.022
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.978 0.022
T42.3 Barbiturates
0.000 0.978 0.022
T42.2 Succinimides and oxazolidinediones
0.000 0.978 0.022
T42.1 Iminostilbenes
0.000 0.978 0.022
T42.0 Hydantoin derivatives
0.000 0.978 0.022
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.978 0.022
T38.9 Other and unspecified hormone antagonists
0.000 0.978 0.022
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.978 0.022
T38.7 Androgens and anabolic congeners
0.000 0.978 0.022
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.978 0.022
T38.5 Other oestrogens and progestogens
0.000 0.978 0.022
T38.4 Oral contraceptives
0.000 0.978 0.022
T38.2 Antithyroid drugs
0.000 0.978 0.022
T38.1 Thyroid hormones and substitutes
0.000 0.978 0.022
T38.0 Glucocorticoids and synthetic analogues
0.000 0.978 0.022
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.978 0.022
T40.8 Lysergide [LSD]
0.000 0.978 0.022
T40.7 Cannabis (derivatives)
0.000 0.978 0.022
T40.5 Cocaine
0.000 0.978 0.022
T40.3 Methadone
0.000 0.978 0.022
T40.1 Heroin
0.000 0.978 0.022
T40.0 Opium
0.000 0.978 0.022
C91 Lymphoid leukaemia
0.000 0.979 0.021
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.979 0.021
T36.9 Systemic antibiotic, unspecified
0.000 0.979 0.020
T36.8 Other systemic antibiotics
0.000 0.979 0.020
T36.7 Antifungal antibiotics, systemically used
0.000 0.979 0.020
T36.6 Rifamycins
0.000 0.979 0.020
T36.5 Aminoglycosides
0.000 0.979 0.020
T36.4 Tetracyclines
0.000 0.979 0.020
T36.3 Macrolides
0.000 0.979 0.020
T36.2 Chloramphenicol group
0.000 0.979 0.020
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.979 0.020
T36.0 Penicillins
0.000 0.979 0.020
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.979 0.020
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.979 0.020
T37.5 Antiviral drugs
0.000 0.979 0.020
T37.4 Anthelminthics
0.000 0.979 0.020
T37.3 Other antiprotozoal drugs
0.000 0.979 0.020
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.979 0.020
T37.1 Antimycobacterial drugs
0.000 0.979 0.020
T37.0 Sulphonamides
0.000 0.979 0.020
T41.5 Therapeutic gases
0.000 0.979 0.020
T41.4 Anaesthetic, unspecified
0.000 0.979 0.020
T41.3 Local anaesthetics
0.000 0.979 0.020
T41.2 Other and unspecified general anaesthetics
0.000 0.979 0.020
T41.1 Intravenous anaesthetics
0.000 0.979 0.020
T41.0 Inhaled anaesthetics
0.000 0.979 0.020
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.979 0.020
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.979 0.020
T47.7 Emetics
0.000 0.979 0.020
T47.6 Antidiarrhoeal drugs
0.000 0.979 0.020
T47.5 Digestants
0.000 0.979 0.020
T47.4 Other laxatives
0.000 0.979 0.020
T47.3 Saline and osmotic laxatives
0.000 0.979 0.020
T47.2 Stimulant laxatives
0.000 0.979 0.020
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.979 0.020
T47.0 Histamine H(2)-receptor antagonists
0.000 0.979 0.020
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.979 0.020
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.979 0.020
T48.5 Anti-common-cold drugs
0.000 0.979 0.020
T48.4 Expectorants
0.000 0.979 0.020
T48.3 Antitussives
0.000 0.979 0.020
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.979 0.020
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.979 0.020
T48.0 Oxytocic drugs
0.000 0.979 0.020
T49.9 Topical agent, unspecified
0.000 0.979 0.020
T49.8 Other topical agents
0.000 0.979 0.020
T49.7 Dental drugs, topically applied
0.000 0.979 0.020
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.979 0.020
T49.5 Ophthalmological drugs and preparations
0.000 0.979 0.020
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.979 0.020
T49.3 Emollients, demulcents and protectants
0.000 0.979 0.020
T49.2 Local astringents and local detergents
0.000 0.979 0.020
T49.1 Antipruritics
0.000 0.979 0.020
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.979 0.020
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.980 0.020
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.980 0.020
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.980 0.020
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.980 0.020
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.980 0.020
T46.7 Peripheral vasodilators
0.000 0.980 0.020
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.980 0.020
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.980 0.020
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.980 0.020
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.980 0.020
T40.4 Other synthetic narcotics
0.000 0.980 0.020
C92 Myeloid leukaemia
0.000 0.980 0.020
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.981 0.019
C83.3 Large cell (diffuse)
0.000 0.981 0.019
T46.1 Calcium-channel blockers
0.000 0.982 0.018
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.982 0.018
C92.0 Acute myeloid leukaemia
0.000 0.982 0.018
C92.1 Chronic myeloid leukaemia
0.000 0.982 0.018
R39.8 Other and unspecified symptoms and signs involving the urinary system
0.000 0.982 0.018
T40.6 Other and unspecified narcotics
0.000 0.982 0.017
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.983 0.017
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.983 0.017
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.983 0.017
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.983 0.017
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.983 0.017
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.983 0.017
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.983 0.017
T44.0 Anticholinesterase agents
0.000 0.983 0.017
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.000 0.984 0.016
M47.92 Spondylosis, unspecified (Cervical region)
0.016 0.984 0.000
C88 Malignant immunoproliferative diseases
0.000 0.984 0.016
M47.9 Spondylosis, unspecified
0.016 0.984 0.000
C83.0 Small cell (diffuse)
0.000 0.984 0.016
M47.90 Spondylosis, unspecified (Multiple sites in spine)
0.016 0.984 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.984 0.015
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.984 0.016
C91.9 Lymphoid leukaemia, unspecified
0.000 0.984 0.015
C91.8 Mature B-cell leukaemia Burkitt-type
0.000 0.984 0.015
C91.7 Other lymphoid leukaemia
0.000 0.984 0.015
C91.6 Prolymphocytic leukaemia of T-cell type
0.000 0.984 0.015
C91.5 Adult T-cell leukaemia
0.000 0.984 0.015
C91.3 Prolymphocytic leukaemia
0.000 0.984 0.015
C91.2 Subacute lymphocytic leukaemia
0.000 0.984 0.015
C91.0 Acute lymphoblastic leukaemia
0.000 0.985 0.015
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.000 0.985 0.015
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.985 0.015
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.985 0.015
C95 Leukaemia of unspecified cell type
0.000 0.985 0.015
C94 Other leukaemias of specified cell type
0.000 0.985 0.015
C93 Monocytic leukaemia
0.000 0.985 0.015
C86 Other specified types of T/NK-cell lymphoma
0.000 0.985 0.015
M47.99 Spondylosis, unspecified (Site unspecified)
0.015 0.985 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.985 0.014
C83.7 Burkitt's tumour
0.000 0.985 0.014
C83.6 Undifferentiated (diffuse)
0.000 0.985 0.014
C83.5 Lymphoblastic (diffuse)
0.000 0.985 0.014
C83.4 Immunoblastic (diffuse)
0.000 0.985 0.014
C83.2 Mixed small and large cell (diffuse)
0.000 0.985 0.014
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.985 0.014
C92.9 Myeloid leukaemia, unspecified
0.000 0.985 0.014
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.000 0.985 0.014
C92.7 Other myeloid leukaemia
0.000 0.985 0.014
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.000 0.985 0.014
C92.5 Acute myelomonocytic leukaemia
0.000 0.985 0.014
C92.4 Acute promyelocytic leukaemia
0.000 0.985 0.014
C92.3 Myeloid sarcoma
0.000 0.985 0.014
C92.2 Subacute myeloid leukaemia
0.000 0.985 0.014
C83.1 Small cleaved cell (diffuse)
0.000 0.986 0.014
C90 Multiple myeloma and malignant plasma cell neoplasms
0.000 0.986 0.014
G40.9 Epilepsy, unspecified
0.000 0.986 0.014
C85.1 B-cell lymphoma, unspecified
0.000 0.986 0.014
R39 Other symptoms and signs involving the urinary system
0.000 0.986 0.014
R39.1 Other difficulties with micturition
0.000 0.986 0.014
M47.97 Spondylosis, unspecified (Lumbosacral region)
0.013 0.987 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.000 0.987 0.013
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.987 0.013
C85.0 Lymphosarcoma
0.000 0.987 0.013
I24.8 Other forms of acute ischaemic heart disease
0.013 0.987 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.987 0.013
M47.98 Spondylosis, unspecified (Sacral and sacrococcygeal region)
0.013 0.987 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.000 0.987 0.012
C81 Hodgkin's disease
0.000 0.988 0.012
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.000 0.988 0.012
C82.6 Cutaneous follicle centre lymphoma
0.000 0.988 0.012
C82.5 Diffuse follicle centre lymphoma
0.000 0.988 0.012
C82.4 Follicular lymphoma grade IIIb
0.000 0.988 0.012
C82.3 Follicular lymphoma grade IIIa
0.000 0.988 0.012
C82.2 Large cell, follicular
0.000 0.988 0.012
C82.1 Mixed small cleaved and large cell, follicular
0.000 0.988 0.012
C82.0 Small cleaved cell, follicular
0.000 0.988 0.012
C88.9 Malignant immunoproliferative disease, unspecified
0.000 0.988 0.012
C88.7 Other malignant immunoproliferative diseases
0.000 0.988 0.012
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.000 0.988 0.012
C88.3 Immunoproliferative small intestinal disease
0.000 0.988 0.012
C88.2 Gamma heavy chain disease
0.000 0.988 0.012
C88.1 Alpha heavy chain disease
0.000 0.988 0.012
M47.95 Spondylosis, unspecified (Thoracolumbar region)
0.012 0.988 0.000
M47.94 Spondylosis, unspecified (Thoracic region)
0.012 0.988 0.000
M47.93 Spondylosis, unspecified (Cervicothoracic region)
0.012 0.988 0.000
M47.91 Spondylosis, unspecified (Occipito-atlanto-axial region)
0.012 0.988 0.000
C84.5 Other and unspecified T-cell lymphomas
0.000 0.989 0.011
C84.9 Mature T/NK-cell lymphoma, unspecified
0.000 0.989 0.011
C84.8 Cutaneous T-cell lymphoma, unspecified
0.000 0.989 0.011
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.000 0.989 0.011
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.000 0.989 0.011
C84.4 Peripheral T-cell lymphoma
0.000 0.989 0.011
C84.3 Lymphoepithelioid lymphoma
0.000 0.989 0.011
C84.2 T-zone lymphoma
0.000 0.989 0.011
C84.1 Sezary's diease
0.000 0.989 0.011
C84.0 Mycosis fungoides
0.000 0.989 0.011
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.000 0.989 0.011
C86.5 Angioimmunoblastic T-cell lymphoma
0.000 0.989 0.011
C86.4 Blastic NK-cell lymphoma
0.000 0.989 0.011
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.000 0.989 0.011
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.000 0.989 0.011
C86.1 Hepatosplenic T-cell lymphoma
0.000 0.989 0.011
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.000 0.989 0.011
C93.9 Monocytic leukaemia, unspecified
0.000 0.989 0.011
C93.7 Other monocytic leukaemia
0.000 0.989 0.011
C93.3 Juvenile myelomonocytic leukaemia
0.000 0.989 0.011
C93.2 Subacute monocytic leukaemia
0.000 0.989 0.011
C93.1 Chronic monocytic leukaemia
0.000 0.989 0.011
C93.0 Acute monocytic leukaemia
0.000 0.989 0.011
C94.7 Other specified leukaemias
0.000 0.989 0.011
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.000 0.989 0.011
C94.5 Acute myelofibrosis
0.000 0.989 0.011
C94.4 Acute panmyelosis
0.000 0.989 0.011
C94.3 Mast cell leukaemia
0.000 0.989 0.011
C94.2 Acute megakaryoblastic leukaemia
0.000 0.989 0.011
C94.1 Chronic erythraemia
0.000 0.989 0.011
C94.0 Acute erythraemia and erythroleukaemia
0.000 0.989 0.011
C95.9 Leukaemia, unspecified
0.000 0.989 0.011
C95.7 Other leukaemia of unspecified cell type
0.000 0.989 0.011
C95.2 Subacute leukaemia of unspecified cell type
0.000 0.989 0.011
C95.1 Chronic leukaemia of unspecified cell type
0.000 0.989 0.011
C95.0 Acute leukaemia of unspecified cell type
0.000 0.989 0.011
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.989 0.011
C96.8 Histiocytic sarcoma
0.000 0.989 0.011
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.989 0.011
C96.6 Unifocal Langerhans-cell histiocytosis
0.000 0.989 0.011
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.000 0.989 0.011
C96.4 Sarcoma of dendritic cells (accessory cells)
0.000 0.989 0.011
C96.3 True histiocytic lymphoma
0.000 0.989 0.011
C96.2 Malignant mast cell tumour
0.000 0.989 0.011
C96.1 Malignant histiocytosis
0.000 0.989 0.011
C96.0 Letterer-Siwe disease
0.000 0.989 0.011
C91.4 Hairy-cell leukaemia
0.000 0.989 0.011
M54.39 Sciatica (Site unspecified)
0.000 0.990 0.010
C90.3 Solitary plasmacytoma
0.000 0.990 0.010
C90.1 Plasma cell leukaemia
0.000 0.990 0.010
C90.0 Multiple myeloma
0.000 0.990 0.010
R39.2 Extrarenal uraemia
0.000 0.990 0.010
R39.0 Extravasation of urine
0.000 0.990 0.010
Z86.0 Personal history of other neoplasms
0.009 0.991 0.000
C81.7 Other Hodgkin's disease
0.000 0.991 0.009
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.000 0.991 0.009
C81.3 Lymphocytic depletion
0.000 0.991 0.009
C81.2 Mixed cellularity
0.000 0.991 0.009
C81.1 Nodular sclerosis
0.000 0.991 0.009
C81.0 Lymphocytic predominance
0.000 0.991 0.009
L40.5 Arthropathic psoriasis
0.000 0.991 0.009
C90.2 Plasmacytoma, extramedullary
0.000 0.991 0.009
M47.96 Spondylosis, unspecified (Lumbar region)
0.008 0.992 0.000
M54.3 Sciatica
0.000 0.992 0.008
M54.36 Sciatica (Lumbar region)
0.000 0.992 0.008
D23.3 Skin of other and unspecified parts of face
0.007 0.993 0.000
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium
0.000 0.993 0.007
Z13.0 Special screening examination for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
0.000 0.993 0.007
D23.7 Skin of lower limb, including hip
0.007 0.993 0.000
I24 Other acute ischaemic heart diseases
0.007 0.993 0.000
M54.38 Sciatica (Sacral and sacrococcygeal region)
0.000 0.994 0.006
M54.35 Sciatica (Thoracolumbar region)
0.000 0.994 0.006
M54.34 Sciatica-Thoracic
0.000 0.994 0.006
M54.33 Sciatica-Cervicothoracic
0.000 0.994 0.006
M54.32 Sciatica-Cervical
0.000 0.994 0.006
M54.31 Sciatica-Occipit-atl-axl
0.000 0.994 0.006
M54.30 Sciatica (Multiple sites in spine)
0.000 0.994 0.006
C81.9 Hodgkin's disease, unspecified
0.001 0.994 0.006
N30.9 Cystitis, unspecified
0.006 0.994 0.000
M54.37 Sciatica (Lumbosacral region)
0.000 0.994 0.006
I24.9 Acute ischaemic heart disease, unspecified
0.006 0.994 0.000
I24.1 Dressler's syndrome
0.006 0.994 0.000
M81.99 Osteoporosis, unspecified (Site unspecified)
0.000 0.995 0.005
O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
0.000 0.995 0.005
N30.2 Other chronic cystitis
0.005 0.995 0.000
K81.1 Chronic cholecystitis
0.000 0.995 0.005
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium
0.000 0.995 0.005
E83.1 Disorders of iron metabolism
0.005 0.995 0.000
L40 Psoriasis
0.000 0.995 0.005
D23 Other benign neoplasms of skin
0.005 0.995 0.000
M17.0 Primary gonarthrosis, bilateral
0.000 0.995 0.005
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.996 0.004
D23.6 Skin of upper limb, including shoulder
0.004 0.996 0.000
Z91.0 Personal history of allergy, other than to drugs and biological substances
0.000 0.996 0.004
I24.0 Coronary thrombosis not resulting in myocardial infarction
0.004 0.996 0.000
Z91.1 Personal history of noncompliance with medical treatment and regimen
0.000 0.996 0.004
O99.3 Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
0.000 0.996 0.004
Z91.5 Personal history of self-harm
0.000 0.996 0.004
Z91 Personal history of risk-factors, not elsewhere classified
0.000 0.996 0.004
O99.7 Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium
0.000 0.996 0.004
O99.5 Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
0.000 0.996 0.004
O99.2 Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
0.000 0.996 0.004
N30 Cystitis
0.004 0.996 0.000
O99.1 Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
0.000 0.996 0.004
D23.0 Skin of lip
0.004 0.996 0.000
L40.9 Psoriasis, unspecified
0.000 0.996 0.004
L40.8 Other psoriasis
0.000 0.996 0.003
L40.4 Guttate psoriasis
0.000 0.996 0.003
L40.3 Pustulosis palmaris et plantaris
0.000 0.996 0.003
L40.2 Acrodermatitis continua
0.000 0.996 0.003
L40.1 Generalised pustular psoriasis
0.000 0.996 0.003
O99.4 Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
0.000 0.996 0.003
M06.9 Rheumatoid arthritis, unspecified
0.000 0.996 0.004
D23.9 Skin, unspecified
0.003 0.996 0.000
L81.9 Disorder of pigmentation, unspecified
0.004 0.996 0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.000 0.997 0.003
L40.0 Psoriasis vulgaris
0.000 0.997 0.003
M54.46 Lumbago with sciatica (Lumbar region)
0.000 0.997 0.003
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament
0.003 0.997 0.000
M47 Spondylosis
0.002 0.997 0.001
M54.4 Lumbago with sciatica
0.000 0.997 0.003
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.997 0.003
Z91.6 Personal history of other physical trauma
0.000 0.997 0.003
M54 Dorsalgia
0.000 0.997 0.003
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)
0.000 0.997 0.003
N30.0 Acute cystitis
0.003 0.997 0.000
Z91.8 Personal history of other specified risk-factors, not elsewhere classified
0.000 0.997 0.003
Z91.7 Personal history of female genital mutilation
0.000 0.997 0.003
Z91.4 Personal history of psychological trauma, not elsewhere classified
0.000 0.997 0.003
Z91.3 Personal history of unhealthy sleep-wake schedule
0.000 0.997 0.003
Z91.2 Personal history of poor personal hygiene
0.000 0.997 0.003
N30.4 Irradiation cystitis
0.003 0.997 0.000
M48.06 Spinal stenosis (Lumbar region)
0.000 0.997 0.003
D23.2 Skin of ear and external auricular canal
0.003 0.997 0.000
N30.1 Interstitial cystitis (chronic)
0.003 0.997 0.000
M54.6 Pain in thoracic spine
0.000 0.997 0.003
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
0.000 0.997 0.002
M06.98 Rheumatoid arthritis, unspecified (Other)
0.000 0.997 0.003
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.000 0.997 0.003
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.000 0.997 0.003
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.000 0.997 0.003
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.000 0.997 0.003
R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
0.000 0.997 0.003
M47.1 Other spondylosis with myelopathy
0.002 0.997 0.001
R79.9 Abnormal finding of blood chemistry, unspecified
0.003 0.997 0.000
D23.1 Skin of eyelid, including canthus
0.003 0.997 0.000
M54.48 Lumbago with sciatica (Sacral and sacrococcygeal region)
0.000 0.997 0.002
M54.47 Lumbago with sciatica (Lumbosacral region)
0.000 0.997 0.002
M54.45 Lumbago with sciatica (Thoracolumbar region)
0.000 0.997 0.002
M54.44 Lumbago with sciatica-Thoracic
0.000 0.997 0.002
M54.43 Lumbago with sciatica-Cervicothoracic
0.000 0.997 0.002
M54.42 Lumbago with sciatica-Cervical
0.000 0.997 0.002
M54.41 Lumbago with sciatica-Occipit-atl-axl
0.000 0.997 0.002
M54.40 Lumbago with sciatica (Multiple sites in spine)
0.000 0.997 0.002
M54.64 Pain in thoracic spine (Thoracic region)
0.000 0.997 0.003
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)
0.000 0.997 0.003
M47.0 Anterior spinal and vertebral artery compression syndromes
0.002 0.997 0.001
M54.0 Panniculitis affecting regions of neck and back
0.000 0.997 0.002
M54.49 Lumbago with sciatica (Site unspecified)
0.000 0.997 0.002
M54.99 Dorsalgia, unspecified (Site unspecified)
0.000 0.997 0.003
N30.3 Trigonitis
0.002 0.997 0.000
N80.9 Endometriosis, unspecified
0.003 0.997 0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.997 0.002
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.997 0.002
M46.9 Inflammatory spondylopathy, unspecified
0.000 0.998 0.002
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand
0.002 0.998 0.000
J86.9 Pyothorax without fistula
0.002 0.998 0.000
M81.9 Osteoporosis, unspecified
0.000 0.998 0.002
R60.0 Localised oedema
0.000 0.998 0.002
M48.0 Spinal stenosis
0.000 0.998 0.002
M54.9 Dorsalgia, unspecified
0.000 0.998 0.002
R50.9 Fever, unspecified
0.000 0.998 0.002
M48.07 Spinal stenosis (Lumbosacral region)
0.000 0.998 0.002
M51.8 Other specified intervertebral disk disorders
0.002 0.998 0.000
G40 Epilepsy
0.000 0.998 0.002
M54.69 Pain in thoracic spine-Site unspe
0.000 0.998 0.002
M54.68 Pain in thoracic spine-Sacral/sacrococ
0.000 0.998 0.002
M54.67 Pain in thoracic spine-Lumbosacral
0.000 0.998 0.002
M54.66 Pain in thoracic spine-Lumbar
0.000 0.998 0.002
M54.65 Pain in thoracic spine (Thoracolumbar region)
0.000 0.998 0.002
M54.63 Pain in thoracic spine (Cervicothoracic region)
0.000 0.998 0.002
M54.62 Pain in thoracic spine-Cervical
0.000 0.998 0.002
M54.61 Pain in thoracic spine-Occipit-atl-axl
0.000 0.998 0.002
M54.60 Pain in thoracic spine (Multiple sites in spine)
0.000 0.998 0.002
M54.8 Other dorsalgia
0.000 0.998 0.002
D23.4 Skin of scalp and neck
0.002 0.998 0.000
M47.12 Other spondylosis with myelopathy (Cervical region)
0.002 0.998 0.000
O21.0 Mild hyperemesis gravidarum
0.002 0.998 0.000
M48.09 Spinal stenosis (Site unspecified)
0.000 0.998 0.002
M80.9 Unspecified osteoporosis with pathological fracture
0.000 0.998 0.002
L30.9 Dermatitis, unspecified
0.000 0.998 0.002
M47.2 Other spondylosis with radiculopathy
0.001 0.998 0.001
M54.2 Cervicalgia
0.000 0.998 0.002
O94-O99 Other obstetric conditions, not elsewhere classified
0.000 0.998 0.002
M47.19 Other spondylosis with myelopathy (Site unspecified)
0.002 0.998 0.001
M47.18 Other spondylosis with myelopathy (Sacral and sacrococcygeal region)
0.002 0.998 0.001
M47.17 Other spondylosis with myelopathy (Lumbosacral region)
0.002 0.998 0.001
M47.16 Other spondylosis with myelopathy (Lumbar region)
0.002 0.998 0.001
M47.15 Other spondylosis with myelopathy (Thoracolumbar region)
0.002 0.998 0.001
M47.14 Other spondylosis with myelopathy (Thoracic region)
0.002 0.998 0.001
M47.13 Other spondylosis with myelopathy (Cervicothoracic region)
0.002 0.998 0.001
M47.11 Other spondylosis with myelopathy (Occipito-atlanto-axial region)
0.002 0.998 0.001
M47.10 Other spondylosis with myelopathy (Multiple sites in spine)
0.002 0.998 0.001
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
0.000 0.998 0.002
O20 Haemorrhage in early pregnancy
0.002 0.998 0.000
S72.10 Pertrochanteric fracture (closed)
0.000 0.998 0.002
E27.4 Other and unspecified adrenocortical insufficiency
0.002 0.998 0.000
O20.8 Other haemorrhage in early pregnancy
0.002 0.998 0.000
M47.09 Anterior spinal and vertebral artery compression syndromes (Site unspecified)
0.002 0.998 0.001
M47.08 Anterior spinal and vertebral artery compression syndromes (Sacral and sacrococcygeal region)
0.002 0.998 0.001
M47.07 Anterior spinal and vertebral artery compression syndromes (Lumbosacral region)
0.002 0.998 0.001
M47.06 Anterior spinal and vertebral artery compression syndromes (Lumbar region)
0.002 0.998 0.001
M47.05 Anterior spinal and vertebral artery compression syndromes (Thoracolumbar region)
0.002 0.998 0.001
M47.04 Anterior spinal and vertebral artery compression syndromes (Thoracic region)
0.002 0.998 0.001
M47.03 Anterior spinal and vertebral artery compression syndromes (Cervicothoracic region)
0.002 0.998 0.001
M47.02 Anterior spinal and vertebral artery compression syndromes (Cervical region)
0.002 0.998 0.001
M47.01 Anterior spinal and vertebral artery compression syndromes (Occipito-atlanto-axial region)
0.002 0.998 0.001
M47.00 Anterior spinal and vertebral artery compression syndromes (Multiple sites in spine)
0.002 0.998 0.001
M54.09 Panniculitis affecting regions of neck and back (Site unspecified)
0.000 0.998 0.002
M54.08 Panniculitis affecting regions of neck and back (Sacral and sacrococcygeal region)
0.000 0.998 0.002
M54.07 Panniculitis affecting regions of neck and back (Lumbosacral region)
0.000 0.998 0.002
M54.06 Panniculitis affecting regions of neck and back (Lumbar region)
0.000 0.998 0.002
M54.05 Panniculitis affecting regions of neck and back (Thoracolumbar region)
0.000 0.998 0.002
M54.04 Panniculitis affecting regions of neck and back (Thoracic region)
0.000 0.998 0.002
M54.03 Panniculitis affecting regions of neck and back (Cervicothoracic region)
0.000 0.998 0.002
M54.02 Panniculitis affecting regions of neck and back (Cervical region)
0.000 0.998 0.002
M54.01 Panniculitis affecting regions of neck and back (Occipito-atlanto-axial region)
0.000 0.998 0.002
M54.00 Panniculitis affecting regions of neck and back (Multiple sites in spine)
0.000 0.998 0.002
M54.90 Dorsalgia, unspecified (Multiple sites in spine)
0.000 0.998 0.002
O20.9 Haemorrhage in early pregnancy, unspecified
0.002 0.998 0.000
O21 Excessive vomiting in pregnancy
0.002 0.998 0.000
M46.98 Inflammatory spondylopathy, unspecified (Sacral and sacrococcygeal region)
0.000 0.998 0.002
M46.97 Inflammatory spondylopathy, unspecified (Lumbosacral region)
0.000 0.998 0.002
M46.95 Inflammatory spondylopathy, unspecified (Thoracolumbar region)
0.000 0.998 0.002
M46.94 Inflammatory spondylopathy, unspecified (Thoracic region)
0.000 0.998 0.002
M46.93 Inflammatory spondylopathy, unspecified (Cervicothoracic region)
0.000 0.998 0.002
M46.91 Inflammatory spondylopathy, unspecified (Occipito-atlanto-axial region)
0.000 0.998 0.002
M46.90 Inflammatory spondylopathy, unspecified (Multiple sites in spine)
0.000 0.998 0.002
M54.1 Radiculopathy
0.000 0.998 0.002
L81.8 Other specified disorders of pigmentation
0.002 0.998 0.000
L81 Other disorders of pigmentation
0.002 0.998 0.000
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)
0.000 0.998 0.002
M81.96 Osteoporosis, unspecified (Lower leg)
0.000 0.998 0.002
M81.95 Osteoporosis, unspecified (Pelvic region and thigh)
0.000 0.998 0.002
M81.94 Osteoporosis, unspecified (Hand)
0.000 0.998 0.002
M81.93 Osteoporosis, unspecified (Forearm)
0.000 0.998 0.002
M81.92 Osteoporosis, unspecified (Upper arm)
0.000 0.998 0.002
M81.91 Osteoporosis, unspecified (Shoulder region)
0.000 0.998 0.002
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)
0.000 0.998 0.002
M48.05 Spinal stenosis (Thoracolumbar region)
0.000 0.998 0.002
M48.04 Spinal stenosis (Thoracic region)
0.000 0.998 0.002
M48.03 Spinal stenosis (Cervicothoracic region)
0.000 0.998 0.002
M48.01 Spinal stenosis (Occipito-atlanto-axial region)
0.000 0.998 0.002
M48.00 Spinal stenosis (Multiple sites in spine)
0.000 0.998 0.002
M46 Other inflammatory spondylopathies
0.000 0.998 0.002
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)
0.000 0.998 0.002
M54.95 Dorsalgia, unspecified (Thoracolumbar region)
0.000 0.998 0.002
M54.93 Dorsalgia, unspecified (Cervicothoracic region)
0.000 0.998 0.002
M54.92 Dorsalgia, unspecified (Cervical region)
0.000 0.998 0.002
M54.91 Dorsalgia, unspecified (Occipito-atlanto-axial region)
0.000 0.998 0.002
O20.0 Threatened abortion
0.002 0.998 0.000
S72.30 Fracture of shaft of femur (closed)
0.000 0.998 0.002
C50.1 Central portion of breast
0.000 0.998 0.002
G40.7 Petit mal, unspecified, without grand mal seizures
0.000 0.998 0.002
G40.4 Other generalised epilepsy and epileptic syndromes
0.000 0.998 0.002
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset
0.000 0.998 0.002
M80 Osteoporosis with pathological fracture
0.000 0.998 0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.